ARWR · Arrowhead Pharmaceuticals, Inc. · Congressional Trades
$41.37
-2.28 (-5.22%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q4 2026 earnings call transcript
Market Cap
$5.85B
Shares
141.37M
Volume · Nov 20
3.91M
Avg daily vol (3M)
2.07M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
| Date | Member | Position | Type | Owner | Amount | Filed | Lag |
|---|---|---|---|---|---|---|---|
| 2023-01-31 | Daniel Goldman | Representative | Sell ST · Arrowhead Pharmaceuticals, Inc. (ARWR) | — Daniel Goldman Grandchildren 1986 Trust > TACS R3K | $1K - $15K | 2023-02-24 | 24d |
Showing 1–1 of 1 trades
Key facts
CIK
879407
CUSIP
04280A100
13F (30d)
467 filings
442 filers
Visit website
Investor relations